Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients with Type 2 Diabetes Mellitus: Exenatide Use Mediates Depressive Scores through Increased Perceived Stress Levels
"As we will build and buy assets, you will often see that these assets do multiple things," Doustdar said in early November
Key results: 12 mg dose: Average weight loss of 24.2 percent of body weight 8 mg dose: Average weight loss of 22.8 percent 4 mg dose: Average weight loss of 17.0 percent Over 90 percent of participants at 8 or 12 mg lost at least 10 percent of body weight Over 75 percent at 12 mg lost at least 20 percent Crucially, the weight loss curve had not yet plateaued at 48 weeks, suggesting longer treatment may produce even greater results
Sanghera said
Semaglutide is a therapy that has demonstrated disease-protective effects in multiple domains
Key insights from the review: Rapid growth of the field since 2019, led by the US, China, and Germany Strong focus on #stroke, #Alzheimers disease, #Parkinsons disease, and bioactive compounds from traditional Chinese medicine Identification of core molecular hubs: STAT3, IL6, TP53, AKT1, and JUN Major mechanistic hotspots include apoptosis, NLRP3 inflammasome, microglial polarization, and NF-B/JAK-STAT/PI3K-AKT pathways Why it matters The analysis highlights a paradigm shift away from one drugone target approaches toward multi-target, systems-level therapeutic strategies, better aligned with the multifactorial nature of neuroinflammatory CNS diseases
.webp)
